Ireland
--:--IST
Starting soon Observational

Assessment of Respiratory Parameters, Aerobic Capacity and Sleep Quality in Thoracic AIS

NCT07187271 · tracked via the Priya Life Science Turkey tracker
Phase
Observational
Started
2025-10-05
Last updated
2025-09-22

Condition(s) studied

Adolescent Idiopathic Scoliosis

Study summary

This study aims to compare respiratory parameters -including pulmonary function and respiratory muscle strength-as well as aerobic capacity and sleep quality in individuals with thoracic adolescent idiopathic scoliosis. Participants will be categorized according to the ISST classification into T-type and TL-type curvature patterns. The study will evaluate differences between these groups using standardized clinical assessments.

Eligibility

Sex
ALL
Min age
12 Years
Max age
20 Years
Healthy volunteers
No
Inclusion Criteria: Individuals with a Cobb angle greater than 10 degrees Adolescents aged 12-20 years diagnosed with thoracic Adolescent Idiopathic Scoliosis, classified as T-type or TL-type according to ISST classification Patients currently undergoing brace treatment Exclusion Criteria: Individuals with a history of spinal surgery Individuals with neurological disorders Individuals with a diagnosed psychiatric disorder Pregnant individuals Individuals who do not provide consent to participate in the study

Primary outcome measure(s)

  • Respiratory Muscle Strength (MIP, MEP) — At baseline (single measurement during study enrollment)
    Respiratory muscle strength will be assessed using an electronic mouth pressure meter (Cosmed Pony FX, ) by measuring Maximal Inspiratory Pressure (MIP) and Maximal Expiratory Pressure (MEP). This outcome evaluates the strength of inspiratory and expiratory muscles in participants with thoracic and thoracolumbar AIS.

Trial sites (1)

FacilityCityRegionStatus
Acıbadem Hospital Istanbul Europe & Central Asia - Upper Middle Income
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07187271 on ClinicalTrials.gov ↗ ← All trials in Turkey